Lista de obras -

A complementary tool for management of disseminated Histoplasma capsulatum var. capsulatum infections in AIDS patients

artículo científico publicado en 2014

Aetiological and morphological spectrum of cardiomyopathies in French Guiana: a retrospective study

scientific article published on 01 May 2020

Development and validation of a bedside score to predict early death in cancer of unknown primary patients

artículo científico publicado en 2009

Development and validation of a model that predicts early death among cancer patients participating in phase I clinical trials investigating cytotoxics

article

Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial.

artículo científico publicado en 2010

Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib

artículo científico publicado en 2017

Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases

artículo científico publicado en 2008

Imatinib as a possible cause of severe rhabdomyolysis

artículo científico publicado en 2008

Imatinib in gastrointestinal stromal tumor: does treatment duration matter?

artículo científico publicado en 2009

Is there a role for discontinuing imatinib in patients with advanced gastrointestinal stromal tumour?

scientific article published on July 2009

Long-term outcome of molecular subgroups of GIST patients treated with standard-dose imatinib in the BFR14 trial of the French Sarcoma Group

artículo científico publicado en 2015

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

artículo científico publicado en 2011

Outcome of patients with platelet-derived growth factor receptor alpha-mutated gastrointestinal stromal tumors in the tyrosine kinase inhibitor era.

artículo científico publicado en 2012

Patterns of care, prognosis, and survival in patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib

artículo científico publicado en 2011

Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial

artículo científico publicado en 2016

Phase II study of oral masitinib mesilate in imatinib-naïve patients with locally advanced or metastatic gastro-intestinal stromal tumour (GIST).

artículo científico publicado en 2010

Predictors of abnormal cytology among HPV-infected women in remote territories of French Guiana

artículo científico publicado en 2018

Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.

artículo científico publicado en 2007

Relationship between imatinib trough concentration and outcomes in the treatment of advanced gastrointestinal stromal tumours in a real-life setting

artículo científico publicado en 2016

Risk Factors for Mortality among HIV-Infected Patients with Disseminated Histoplasmosis

scientific article published on 30 November 2020

Serum creatine kinase increase in patients treated with tyrosine kinase inhibitors for solid tumors.